Abstract—This study was aimed at the identification of the most significant clinical, anatomical, and molecular risk factors of the occurrence and progression of endometrial hyperplastic processes and the development of endometrial malignant transformation in women of perimenopause age taking statistical analysis into account. The results enabled us to find statistically significant risk factors for endometrial cancer. The degree of cancer risk was calculated using the method of binary logistic regression; the effective tactics of management of patients with endometrial hyperplastic processes in perimenopause was chosen.
Similar content being viewed by others
REFERENCES
V. I. Kiselev, I. S. Sidorova, A. L. Unanyan, et al., Hyperplasias of Female Reproductive Organs: Theory and Practice (Medpraktika-M, Moscow, 2011) [in Russian].
A. N. Strizhakov and A. I. Davydov, Benign Uterine Diseases (GEOTAR-Media, Moscow, 2011) [in Russian].
Gynecology: National Guidelines, Ed. by V. I. Kulakov, I. B. Manukhin, and G. M.Savel’eva (GEOTAR-Media, Moscow, 2007) [in Russian].
Yu. E. Dobrokhotova and L. V. Saprykina, Endometrial Hyperplasia (GEOTAR-Media, Moscow, 2016) in Russian].
L. A. Ashrafyan and V. I. Kiselev, Tumors of Reproductive Organs: Etiology and Pathogenesis (Dimitrade Graphgic Group, Moscow, 2007) [in Russian].
The State of Oncological Service to the Population of Russia as of 2017, Ed. by A. D. Kaprin, V. V. Starinskii, and G. V. Petrova (Gertsen Oncological Research Institute, Moscow, 2018) [in Russian].
R. R. Sagindykova, S. I. Askol’skaya, E. A. Kogan, and V. D. Chuprynin, Akusher. Ginekol., No. 7, 22 (2014).
G. E. Chernukha, G. T. Sukhikh, V. P. Smetnik, et al., Probl. Reprod. 10 (4), 30 (2004).
V. I. Kiselev, I. S. Sidorova, A. L. Unanyan, et al., Hyperplasias of Female Reproductive Organs: Theory and Practice Medpraktika-M, Moscow, 2011) [in Russian].
S. A. Bapat, Reproduction 140 (1), 33 (2010).
A. Fabian, G. Vereb, and J. Szollosi, Cytometry A 83 (1), 62 (2013).
A. I. Ishchenko, E. A. Kudrina, and I. V. Stanoevich, Vrach, No. 8, 14 (2008).
C. L. Trimble, J. Kauderer, R. Zaino, et al., Cancer 106, 812 (2006).
E. I. Joensuu, W. M. Abdel-Rahman, M. Ollikainen, et al. Cancer Res. 68, 4597 (2008).
M. R. Wise, V. Jordan, A. Lagas, et al., Am. J. Obstet. Gynecol. 214 (6), 689.e1 (2016).
G. M Savel’eva and V. N. Serov, Endometrial Precancer (editsina, Moscow, 1980) [in Russian].
Ya. V. Bikhman, Oncogynecology: A Manual (Meditsina, Leningrad, 1989) [in Russian].
Y. Kuribayashi, K. Nakagawa, R. Sugiyama, et al., J. Obstet. Gynaecol. Res. 43 (9), 1465 (2017).
J. M. Rubatt, B. M. Slomovitz, T. W. Burke, et al., Gynecol. Oncol. 99 (2), 4726 (2005).
A. J. Ryan, B. Susil, T. W. Jobling, et al., Cell Tissue Res. 322, 53 (2005).
R. Machtinger, J. Korach, A. Padoa, et al., Int. J. Gynecol. Cancer 15, 3258 (2005).
I. V. Stolyarova, B. A. Minko, and B. R. Sirazitdinov, in Proc. 19 Int. Congr. on Anti-Cancer Treatment (Paris, 2008), pp. 255–256.
I. S. Sidorova, T. D. Guriev, I. N. Kapustina, et al., Med. Vizualizatsiya, No. 2, 88 (2001).
I. D. Gallos, M. Alazzam, T. J. Clark, et al., Management of Endometrial Hyperplasia (Green-top Guideline No. 67, RCOG/BSGE Joint Guideline, 2016).
V. Chandra, J. J. Kim, D. M. Benbrook, et al., J. Gynecol. Oncol. 27 (1), e8 (2016).
M. J. Hill, E. D. Levens, and A. H. Decherney, ACOG Practice Bull. 120, 197 (2012).
T. J. Clark, D. Neelakantan, and J. K. Gupta, Eur. J. Obstet. Gynecol. Reprod. Biol. 125 (2), 259 (2006).
L. C. Horn, U. Schnurbusch, B. Hentschel, et al., Int. J. Gynecol. Cancer 14 (2), 348 (2004).
B. E. Montgomery, G. S. Daum, and C. J. Dunton, Rev. Obstet. Gynecol. Survey 59 (5), 368 (2004).
General Human Pathology: A Manual for Physicians, Ed. by A. I. Strukov, V. V. Serov, and D. S. Sarkisov (Meditsina, Moscow, 1990) [in Russian].
S. P. Ho, K. T. Tan, M. W. Pang, and T. H. Ho, Singapore Med. J. 38 (1), 11 (1997).
F. H. Igney and P. H. Krammer, Nat. Rev. Cancer 2 (4), 277 (2002).
K. Kato, T. Takao, A. Kuboyama, et al., Am. J. Pathol. 176 (1), 381 (2010).
P. P. Szotek, R. Pieretti-Vanmarcke, P. T. Masiakos, et al., Proc. Natl. Acad. Sci. U. S. A. 103 (30), 11154 (2006).
M. F. Clarke, J. E. Dick, P. B. Dirks, et al., Cancer Res. 66 (19), 9339 (2006).
A. B. Alvero, R. Chen, H. H. Fu, et al., Cell Cycle 8 (1), 158 (2009).
R. W. Chan, K. E. Schwab, and C. E. Gargett, Biol. Reprod. 70 (6), 1738 (2004).
A. M. Friel, P. A. Sergent, C. Patnaude, et al., Cell Cycle 7 (2), 242 (2008).
C. E. Gargett, Aust. N. Z. J. Obstet. Gynaecol. 46 (3), 250 (2006).
S. A. Bapat, Reproduction 140 (1), 33 (2010). https://doi.org/10.1530/REP-09-0389
N. Rahadiani, J.-I. Ikeda, S. Mamat, et al., Cancer Sci. 102, 903 (2011).
M. Gotte, B. Greve, R. Kelsch, et al., Int. J. Cancer 129 (8), 2042 (2011).
H. R. Scholer, S. Ruppert, N. Suzuki, et al., Nature 344, 435 (1990).
Y. Wu, S. Liu, H. Xin, et al., Cancer 117, 3989 (2011).
S. Peng, N. J. Maihle, and Y. Huang, Oncogene 29, 2153 (2010).
X. Zhou, Y. P. Zhou, G. R. Huang, et al., Int. J. Gynecol. Pathol. 30 (3), 262 (2011).
C. E. Edling and B. Hallberg, Int. J. Biochem. Cell Biol-. 39 (11), 1995 (2007).
S. Kyo and K. Kato, Semin. Reprod. Med. 33 (5), 341 (2015).
S. Kyo, Y. Maida, and M. Inoue, Cancer Lett. 308 (2), 123 (2011).
N. B. Berry and S. A. Bapat, J. Ovarian Res. 1, 8 (2008). https://doi.org/10.1186/1757-2215-1-8
E. N. Burgova, L. V. Adamyan, N. A. Tkachev, et al., Biophysics (Moscow) 57, 87 (2012).
A. F. Vanin, E. N. Burgova, and L. V. Adamyan, Austin J. Reprod. Med. Infertil. 2, 1019 (2015).
E. N. Burgova, Y. I. Christidis, A. V. Kurkov, et al., Cell Biochem. Biophys. 77, 89 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest. The authors state that there is no conflict of interest.
Statement of compliance with standards of research involving humans as subjects. All procedures performed in the human study are in accordance with the ethical standards of the institutional and/or national research ethics Committee and the 1964 Helsinki Declaration and its subsequent changes or comparable ethical standards. Informed voluntary consent was obtained from each of the participants included in the study.
Additional information
Translated by E. Puchkov
Abbreviations: EHP, endometrial hyperplastic processes; CSC, cancer stem cells; RR, the relative risk factor of endometrial cancer.
Rights and permissions
About this article
Cite this article
Kogan, E.A., Unanyan, A.L., Namiot, V.A. et al. A Precision Approach to the Diagnosis and Choice of Tactics in the Treatment of Endometrial Hyperplasia in Perimenopause. BIOPHYSICS 64, 649–656 (2019). https://doi.org/10.1134/S0006350919040055
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006350919040055